Clinical Trial Update: A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)

View source ↗

Summary

A clinical trial evaluating whether factors can predict how liver tumors or liver metastases respond to trans-arterial embolization has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Liver Cancer, Liver Metastases | Status: WITHDRAWN